US Centers for Disease Control and Prevention (CDC) experts are discussing narrowing the use of COVID-19 booster shots, particularly recommending them only for individuals at high risk of severe illness. The panel’s recommendation, set to be voted on in June, aims to target those most vulnerable to severe COVID-19. Experts have expressed concerns about implementing such an approach, citing difficulties and potential confusion among the public. A majority of the CDC’s working group favors a risk-based approach, but some warn it may send the wrong message. The change could impact vaccine sales for pharmaceutical companies like Pfizer and Moderna. Additionally, the panel will discuss the ongoing US measles outbreak, which has infected over 700 people mostly in unvaccinated areas.
Source: https://www.reuters.com/business/healthcare-pharmaceuticals/us-cdc-advisers-review-vaccine-guidelines-after-months-long-delay-2025-04-15